189 related articles for article (PubMed ID: 30308271)
1. Pollen grains as a novel microcarrier for oral delivery of proteins.
Lale SV; Gill HS
Int J Pharm; 2018 Dec; 552(1-2):352-359. PubMed ID: 30308271
[TBL] [Abstract][Full Text] [Related]
2. Development of pH-responsive organic-inorganic hybrid nanocomposites as an effective oral delivery system of protein drugs.
Lee SH; Song JG; Han HK
J Control Release; 2019 Oct; 311-312():74-84. PubMed ID: 31487499
[TBL] [Abstract][Full Text] [Related]
3. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
Xu B; Zhang W; Chen Y; Xu Y; Wang B; Zong L
Int J Biol Macromol; 2018 Jul; 113():534-542. PubMed ID: 29408613
[TBL] [Abstract][Full Text] [Related]
4. A laminated polymer film formulation for enteric delivery of live vaccine and probiotic bacteria.
de Barros JMS; Scherer T; Charalampopoulos D; Khutoryanskiy VV; Edwards AD
J Pharm Sci; 2014 Jul; 103(7):2022-2032. PubMed ID: 24801679
[TBL] [Abstract][Full Text] [Related]
5. Ragweed pollen as an oral vaccine delivery system: Mechanistic insights.
Uddin MJ; Gill HS
J Control Release; 2017 Dec; 268():416-426. PubMed ID: 29054371
[TBL] [Abstract][Full Text] [Related]
6. Influence of lidocaine forms (salt vs. freebase) on properties of drug-eudragit® L100-55 extrudates prepared by reactive melt extrusion.
Liu X; Ma X; Kun E; Guo X; Yu Z; Zhang F
Int J Pharm; 2018 Aug; 547(1-2):291-302. PubMed ID: 29883791
[TBL] [Abstract][Full Text] [Related]
7. Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles.
Shastri PN; Ubale RV; D'Souza MJ
Drug Dev Ind Pharm; 2013 Feb; 39(2):164-75. PubMed ID: 22591196
[TBL] [Abstract][Full Text] [Related]
8. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
[TBL] [Abstract][Full Text] [Related]
9. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.
Sawant KP; Fule R; Maniruzzaman M; Amin PD
Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic understanding of ragweed pollen for oral vaccine delivery.
Park K
J Control Release; 2017 Dec; 268():427. PubMed ID: 29217275
[No Abstract] [Full Text] [Related]
11. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet.
Park HJ; Jung HJ; Ho MJ; Lee DR; Cho HR; Choi YS; Jun J; Son M; Kang MJ
Eur J Pharm Sci; 2017 May; 102():172-179. PubMed ID: 28279763
[TBL] [Abstract][Full Text] [Related]
12. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
Khan MZ; Prebeg Z; Kurjaković N
J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
[TBL] [Abstract][Full Text] [Related]
14. The atypically high modulus of pollen exine.
Qu Z; Meredith JC
J R Soc Interface; 2018 Sep; 15(146):. PubMed ID: 30232244
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Eudragit® L100-coated chitosan-based nanoparticles for oral enoxaparin delivery.
Patriota YBG; Arruda IES; de Jesus Oliveira AC; de Oliveira TC; de Lemos Vasconcelos Silva E; Chaves LL; de Oliveira Silva Ribeiro F; da Silva DA; de La Roca Soares MF; Soares-Sobrinho JL
Int J Biol Macromol; 2021 Dec; 193(Pt A):450-456. PubMed ID: 34688680
[TBL] [Abstract][Full Text] [Related]
16. Development of delayed-release proliposomes tablets for oral protein drug delivery.
Tantisripreecha C; Jaturanpinyo M; Panyarachun B; Sarisuta N
Drug Dev Ind Pharm; 2012 Jun; 38(6):718-27. PubMed ID: 21999514
[TBL] [Abstract][Full Text] [Related]
17. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
Khan MZ; Stedul HP; Kurjaković N
Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
[TBL] [Abstract][Full Text] [Related]
18. Ionotropically cross-linked pH-sensitive IPN hydrogel matrices as potential carriers for intestine-specific oral delivery of protein drugs.
El-Sherbiny IM; Salama A; Sarhan AA
Drug Dev Ind Pharm; 2011 Feb; 37(2):121-30. PubMed ID: 20615156
[TBL] [Abstract][Full Text] [Related]
19. Development of enteric submicron particle formulation of papain for oral delivery.
Sharma M; Sharma V; Panda AK; Majumdar DK
Int J Nanomedicine; 2011; 6():2097-111. PubMed ID: 22114474
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
